Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Karl Björkström"'
Publikováno v:
Liver International. 42:820-828
Individuals with non-alcoholic fatty liver disease (NAFLD) may be at greater risk of cancer. This study aimed to investigate the risk of hepatic and extrahepatic cancer compared to the general population in a population-based cohort of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::227fd2266bb3f7a77d56666f3aef7f30
https://doi.org/10.1111/liv.15195
https://doi.org/10.1111/liv.15195
Autor:
Karl Björkström, Johan Hoffstedt, Per Stål, Bonnie Bengtsson, Magnus Holmer, Hannes Hagström, Annika Staaf
Publikováno v:
European Journal of Gastroenterology & Hepatology. 33:1420-1426
BACKGROUND AND AIMS It is unclear if improving glycemic control in persons with type 2 diabetes (T2D) also has liver-related effects. We aimed to evaluate if a personalized treatment program associates with improvement of liver-related parameters in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7df0bc5323a425ff4634a746ff8a0fb
https://doi.org/10.1097/meg.0000000000001882
https://doi.org/10.1097/meg.0000000000001882
Autor:
Hannes Hegmar, Magnus Holmer, Karl Björkström, Hannes Hagström, Andrea Lindfors, Bonnie Bengtsson, Erik von Seth
Publikováno v:
Scandinavian journal of gastroenterology. 56(6)
Patients with liver cirrhosis have high mortality, often estimated by the Child-Pugh or MELD scores. Etiologies of cirrhosis are rapidly shifting, and it is unclear if these scores perform similarly across subgroups of patients. Here, we describe the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b653a6d1632cc89ec0436a0ab49bea
https://pubmed.ncbi.nlm.nih.gov/33872099
https://pubmed.ncbi.nlm.nih.gov/33872099
Publikováno v:
Clinical Gastroenterology and Hepatology. 15:1461-1468
Background & Aims Nonalcoholic fatty liver disease (NAFLD) is a strong risk factor for development of type 2 diabetes, but little is known about how long-term NAFLD or its histologic features affect risk. We aimed to investigate the cumulative incide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109ac116c38d1e38cb92da74a8231376
https://doi.org/10.1016/j.cgh.2017.04.040
https://doi.org/10.1016/j.cgh.2017.04.040
Autor:
Ylva Trolle-Lagerros, Björn Eliasson, Stefan Franzén, Mervete Miftaraj, Karl Björkström, Soffia Gudbjörnsdottir, Ann-Marie Svensson, Hannes Hagström
Publikováno v:
Clinical Gastroenterology and Hepatology. 17:2769-2775.e4
Background & Aims Type 2 diabetes is a risk factor for development of cirrhosis and hepatocellular carcinoma. However, risk factors that identify persons with the highest risk for these outcomes are missing from unselected, population-based cohorts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a55435317fc38c8d98f14aee2c1e9122
https://doi.org/10.1016/j.cgh.2019.04.038
https://doi.org/10.1016/j.cgh.2019.04.038